Molecular and cellular basis of interleukin 12 activity in prophylaxis and therapy against infectious diseases

Molecular Medicine Today

Volumn 2, Issue 6, 1996, Pages 258-267

  Gazzinelli, Ricardo T ^a,b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12;

ANIMAL; CELLULAR IMMUNITY; HUMAN; IMMUNOLOGY; INFECTION; INFECTION CONTROL; METHODOLOGY; REVIEW;

ANIMALS; HUMANS; IMMUNITY, CELLULAR; INFECTION; INFECTION CONTROL; INTERLEUKIN-12;

EID: 0030161312     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/1357-4310(96)88807-1     Document Type: Review

References (41)

1. Trinchieri, G. (1995) Interleukin-12: a pro-inflammatory cytokine with immuno-regulatory functions that bridge innate resistance and antigen-specific adaptative immunity, Ann. Rev. Immunol. 13, 252-276
2. Trinchieri, G. and Scott, P. (1995) 62nd Forum in Immunology: immunoregulation by interleukin-12, Res. Immunol. 146, 419-656
3. Biron, C.A. and Gazzinelli, R.T. (1995) Effects of IL-12 on immune responses to microbial infections: a key mediator in regulating disease outcome. Curr. Opin. Immunol. 7, 485-496
4. Kobayashi, M. et al. (1989) Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes, J. Exp. Med. 170, 827-846
5. Wolf, S. et al. (1991) Cloning of cDNA for natural killer stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 146, 3074-3081
6. D'Andrea, A. et al. (1992) Production of natural killer cell stimulatory factor (NKSF/IL-12) by peripheral blood mononuclear cells. J. Exp. Med., 176, 1387-1398
7. Gazzinelli, R.T. et al. (1993) Interleukin 12 is required for the T-lymphocyte independent induction of interferon-γ by an intracellular parasite and induces resistance in T-cell-deficient hosts, Proc. Natl Acad. Sci. USA 90, 6115-6119
8. Chehimi, J. et al. (1994) Impaired interleukin 12 production in human immuno-deficiency virus-infected patients, J. Exp. Med. 179, 1361-1366
9. + T cells during initiation of infection, J. Exp. Med. 179, 447-456
10. Carrera, L. et al. (1996) Leishmania promastigotes selectively inhibit IL-12 induction in bone-marrow derived macrophages from susceptible and resistant mice, J. Exp. Med. 183, 515-526
11. Grunvald, E. et al. Biochemical characterization and protein kinase C dependency of monokine inducing activities in Toxoplasma gondii. Infect. Immun. (in press)
12. Yoshida, A., Koide, Y., Uchijima, M. and Yoshida, T.O. (1994) IFN-γ induces IL-12 mRNA expression by a murine macrophage cell line, J774, Biochem. Biophys. Res. Commun. 198, 857-861
13. Ma, X. et al. (1996) The interleukin 12 p40 gene promoter is primed by IFN-γ in monocytic cells, J. Exp. Med. 183, 147-157
14. Tripp, C.S. et al. (1994) Neutralization of IL-12 decreases resistance to Listeria in SCID and CB-17 mice, reversal by IFN-γ. J. Immunol. 152, 1883-1887
15. Gazzinelli, R.T. et al. (1994) Parasite induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii, J. Immunol. 153, 2533-2543
16. + T cells to enhance priming for IFN-γ and diminishes IL-4 inhibition of such priming, Proc. Natl Acad. Sci. USA 90, 10188-10192
17. Tripp, C.S., Kanagawa, O. and Unanue, E.R. (1995) Secondary response to Listeria infection requires IFN-γ but is partially independent of IL-12, J. Immunol. 155, 3427-3432
18. Clerici, M. et al. (1993) Restoration of HIV-specific cell-mediated immune responses by interleukin 12 in vitro, Science 262, 1721-1724
19. Gazzinelli, R.T., Giese, N.A. and Morse, H.C., III (1994) In vivo treatment with interleukin 12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS), J. Exp. Med. 180, 2199-2208
20. Orange, CA, Wolf, S.F. and Biron, C.A. (1994) Effects of IL-12 on the response and susceptibility to experimental viral infections. J. Immunol. 152, 1253-1264
21. Virgil, E., Schijns, C.J., Haagmans, B.L. and Horzinek, M.C. (1995) IL-12 stimulates an antiviral type 1 cytokine response but lacks adjuvant activity in IFN-γ-receptor deficient mice. J. Immunol. 155, 2525-2532
22. Bi. Z. et al. (1995) IL-12 promotes enhanced recovery from vesicular stomatitis virus infection of the central nervous system. J. Immunol. 155, 5684-5689
23. + T cells. J. Immunol. 156, 1458-1468
24. Flynn, J.L. et al. (1995) IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J. Immunol. 155, 2515-2524
25. Sieling, P.A. et al. (1994) IL-12 regulates T helper 1 cytokine responses in human infectious disease. J. Immunol. 153, 3639-3647
26. Wyzocka, M. et al. (1995) Interleukin 12 is required for IFN-γ production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol. 25, 672-676
27. Romani, L. et al. (1994) IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis. J. Immunol. 153, 5167-5175
28. Zhou, P. et al. (1995) IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-γ, J. Immunol. 155, 785-795
29. Clemons, K.V., Brummer, E. and Stevens, D.A. (1994) Cytokine treatment of central nervous system infection: efficacy of IL-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis, Antimicrob. Agents Chemother, 38, 460-464
30. Sypeck, T. et al. (1993) Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective type 1 immune response. J. Exp. Med. 177, 1797-1802
31. Heinzel, F. et al. (1993) Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med., 177, 1505-1509
32. Afonso, L.C. et al. (1994) The adjuvant effect of interleukin 12 in a vaccine against Leishmania major. Science 263, 235-237
33. Nabora, G.S., Afonso, L.C.C., Farrell, J.P. and Scott, P. (1995) A switch from a Th2 to Th1 type response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and pentostam. Proc. Natl Acad. Sci. USA 92, 3142-3146
34. Murray, H.W. and Hariprashad, J. (1995) Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis, J. Exp. Med. 181, 387-391
35. Stevenson, M.M., Tam, M.F., Wolf, S.F. and Sher, A. (1995) IL-12-induced protection against blood-stage Plasmodium chaubaudi requires IFN-γ and TNF-α and occurs via nitric oxide-dependent mechanism. J. Immunol. 155, 2545-2556
36. Sedegah, M. Finkelman, F. and Hoffman, S.L. (1994) Interleukin 12: induction of IFN-γ dependent protection against malaria. Proc. Natl Acad. Sci. USA 91, 10700-10702
37. Urban, J.F et al. (1996) IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum, J. Immunol. 156, 263-268
38. Aliberti, J.C.S. et al. (1995) IL-12 mediates resistance to Trypanosoma cruzi infection in susceptible mice and is produced by normal murine macrophages cultured with live trypomastigotes, Mem. Inst. Oswaldo Cruz 90 (Suppl. I), 172
39. Wynn, T.A. et al. (1995) An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 376, 594-596
40. Gately, M.K. et al. (1994) Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-γ in vivo. Int. Immunol. 6, 157-167
41. Fauci, A.S. (1993) Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 262, 1011-1018